Текущие активы Изменить Дата
Agios Pharmaceuticals USD 752.1M 34.43M 2026-09
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
Arrowhead Research USD 1.67B 168.34M 2026-06
Astellas Pharma JPY 1.44T 41.22B 2026-09
BioCryst Pharmaceuticals USD 531.15M 46.47M 2026-09
BioMarin Pharmaceutical USD 3.92B 50.99M 2026-09
Celltrion KRW 493.66B 12.09B 2026-06
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Divis Laboratories Ltd INR 110.96B 12.53B 2026-03
Exelixis USD 1.32B 70.8M 2026-09
Halozyme Therapeutics USD 933.02M 70.01M 2026-06
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Kangmei Pharma CNY 6.66B 143.43M 2026-06
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Moderna USD 5.82B 45M 2026-06
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Neurocrine Biosciences USD 2.01B 370.7M 2026-09
Novartis USD 28.75B 1.4B 2026-09
Omeros USD 69.65M 26.53M 2025-06
OPKO Health USD 500.24M 35.13M 2026-06
Organigram Holdings CAD 280.09M 30M 2026-06
Ovoca Bio EUR 2.07M 510K 2025-12
Pfizer USD 45.01B 3.65B 2026-09
Pharma Mar EUR 295.56M 14.62M 2026-09
PTC Therapeutics USD 2.54B 79.58M 2026-09
Qiagen NV USD 1.66B 116.37M 2026-06
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sarepta Therapeutics USD 2.22B 86.05M 2026-06
Sartorius EUR 1.65B 8.4M 2026-09
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Tilray USD 729.32M 28.18M 2025-09
Ultragenyx Pharmaceutical USD 544M 62M 2026-09
Vertex Pharmaceuticals USD 11.69B 857.4M 2026-09
Zealand Pharma A/S 15.02B 652.12M 2026-03
Zz Pientze Pharmaceu CNY 13.48B 2.32B 2026-09